The subsequent experiments demonstrated that curcumin analogue, C66, as an inhibitor of CBP/p300, can protect renal injury in diabetic mice via restraining the expression of JNK and inhibiting the diabetes-related increase in the expression of p300/CBP and acetylation of H3K9/14Ac[88]. The gene discussed is EP300; the disease is diabetes mellitus.